Hendershot Investments Inc. Increases Stake in Molina Healthcare, Inc. (NYSE:MOH)

Hendershot Investments Inc. increased its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 81.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,010 shares of the company's stock after acquiring an additional 8,078 shares during the quarter. Hendershot Investments Inc.'s holdings in Molina Healthcare were worth $6,507,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Molina Healthcare by 18.4% during the first quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company's stock worth $2,151,448,000 after purchasing an additional 1,001,372 shares in the last quarter. Norges Bank bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $214,801,000. Durable Capital Partners LP bought a new stake in Molina Healthcare in the first quarter valued at approximately $214,363,000. Invesco Ltd. lifted its position in Molina Healthcare by 151.6% in the first quarter. Invesco Ltd. now owns 893,693 shares of the company's stock valued at $298,128,000 after purchasing an additional 538,493 shares during the last quarter. Finally, State Street Corp lifted its position in Molina Healthcare by 25.6% in the first quarter. State Street Corp now owns 2,457,008 shares of the company's stock valued at $819,633,000 after purchasing an additional 501,107 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on MOH. Bank of America downgraded Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective for the company. in a research report on Thursday, March 28th. Wells Fargo & Company increased their target price on Molina Healthcare from $420.00 to $440.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 20th. Cantor Fitzgerald reissued an "overweight" rating and issued a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, April 4th. StockNews.com cut Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 8th. Finally, Barclays started coverage on Molina Healthcare in a research note on Wednesday, March 6th. They issued an "equal weight" rating and a $437.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and an average target price of $395.82.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares of the company's stock, valued at approximately $4,494,567.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Mark Lowell Keim sold 15,000 shares of the business's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The disclosure for this sale can be found here. Insiders sold 16,711 shares of company stock worth $6,472,517 in the last quarter. 1.11% of the stock is owned by corporate insiders.

Molina Healthcare Stock Performance

Shares of NYSE MOH traded down $2.84 during trading on Wednesday, hitting $377.13. The company had a trading volume of 317,007 shares, compared to its average volume of 383,816. The stock has a 50 day simple moving average of $393.72 and a 200 day simple moving average of $369.58. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.54 and a current ratio of 1.54. Molina Healthcare, Inc. has a 12 month low of $266.35 and a 12 month high of $423.92. The firm has a market capitalization of $22.09 billion, a P/E ratio of 20.08, a price-to-earnings-growth ratio of 1.07 and a beta of 0.47.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.31 by $0.07. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The firm had revenue of $9.05 billion during the quarter, compared to analysts' expectations of $8.35 billion. During the same quarter last year, the business posted $4.10 earnings per share. The firm's revenue was up 10.0% on a year-over-year basis. As a group, analysts anticipate that Molina Healthcare, Inc. will post 23.62 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.